Cargando…
SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer’s disease
Cerebrospinal fluid (CSF) Aβ42 and tau protein levels are established diagnostic biomarkers of Alzheimer’s disease (AD). However, their inadequacy to represent clinical efficacy in drug trials indicates the need for new biomarkers. Sequential window acquisition of all theoretical fragment ion spectr...
Autores principales: | Park, Sun Ah, Jung, Jin Myung, Park, Jun Sung, Lee, Jeong Ho, Park, Bumhee, Kim, Hyung Jun, Park, Jeong-Ho, Chae, Won Seok, Jeong, Jee Hyang, Choi, Seong Hye, Baek, Je-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198522/ https://www.ncbi.nlm.nih.gov/pubmed/32366888 http://dx.doi.org/10.1038/s41598-020-64461-y |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea
por: Park, Sun Ah, et al.
Publicado: (2017) -
Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017) -
The Correlation Study between Plasma Aβ Proteins and Cerebrospinal Fluid Alzheimer's Disease Biomarkers
por: Shin, Ho Sik, et al.
Publicado: (2016) -
Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
por: Park, Min Jeong, et al.
Publicado: (2011) -
Catalytic pyrolysis of Laminaria japonica over nanoporous catalysts using Py-GC/MS
por: Lee, Hyung Won, et al.
Publicado: (2011)